Journal of Clinical Oncology · 1998 · 217 citations · 45 references
Decision-analysis modeling indicates the potential cost-effectiveness of [18F]2-fluoro-2-deoxy-D-glucose (FDG)-PET in the management of SPN. Furthermore, the decision trees developed can be used to model various features of the management of SPN, including modeling the cost-effectiveness of other newly emerging technologies.
45
Otto Warbürg · Science · 1956 · 13.1K citations
Human Cell, Months1,079total Citations9,249last 6, Engineering +13
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Edward F. Patz, Val J. Lowe, John M. Hoffman et al. · Radiology · 1993 · 512 citations
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
P. Som, Harold Atkins, D. Bandoypadhyay et al. · Journal of Computer Assisted Tomography · 1980 · 502 citations
A convenient approximation of life expectancy (the “DEALE”)
J. Robert Beck, Stephen G. Pauker, Jonathan E. Gottlieb et al. · The American Journal of Medicine · 1982 · 476 citations